Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis

BMC Medicine

Volumn 10, Issue , 2012, Pages

  Ling, Xuefeng B ^a   Macaubas, Claudia ^a   Alexander, Heather C ^b   Wen, Qiaojun ^a   Chen, Edward ^a   Peng, Sihua ^a   Sun, Yue ^a   Deshpande, Chetan ^a   Pan, Kuang Hung ^a   Lin, Richard ^a   Lih, Chih Jian ^a   Chang, Sheng Yung P ^b   Lee, Tzielan ^a   Sandborg, Christy ^a   Begovich, Ann B ^b   Cohen, Stanley N ^a   Mellins, Elizabeth D ^a  

^a STANFORD UNIVERSITY   (United States)

^b CELERA   (United States)

Author keywords

Arthritis; Inflammation; Juvenile idiopathic arthritis (JIA); Polyarticular JIA; Systemic JIA; Transcriptional analysis

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 10; INTERLEUKIN 4;

ADOLESCENT; ADULT; AFFECTED JOINT COUNT; ARTICLE; CHILD; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; JOINT EXAMINATION; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SYSTEMIC JUVENILE RHEUMATOID ARTHRITIS;

ARTHRITIS, JUVENILE RHEUMATOID; BLOOD SEDIMENTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; JOINTS; LEUKOCYTES, MONONUCLEAR; MALE; PATHOLOGY, MOLECULAR;

EID: 84867673893     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-10-125     Document Type: Article

References (86)

1. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur A-M, Suarez-Almazor ME, Woo P. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004, 31:390-392.
2. Woo P. Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome. Nat Clin Pract Rheumatol 2006, 2:28-34. 10.1038/ncprheum0084, 16932649.
3. Kumar S, Vaidyanathan B, Gayathri S, Rajam L. Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review. Rheumatol Int 2010,
4. Wittkowski H, Frosch M, Wulffraat N, Goldbach Mansky R, Kallinich T, Kuemmerle Deschner J, Frühwald M, Dassmann S, Pham T-H, Roth J, Foell D. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum 2008, 58:3924-3931. 10.1002/art.24137, 2680303, 19035478.
5. Lomater C, Gerloni V, Gattinara M, Mazzotti J, Cimaz R, Fantini F. Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. J Rheumatol 2000, 27:491-496.
6. Singh-Grewal D, Schneider R, Bayer N, Feldman BM. Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. Arthritis Rheum 2006, 54:1595-1601. 10.1002/art.21774, 16645998.
7. Efthimiou P, Kontzias A, Ward C, Ogden N. Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?. Nat Clin Pract Rheumatol 2007, 3:328-335. 10.1038/ncprheum0510, 17538564.
8. Syed R, Gilliam B, Moore T. Rheumatoid factors and anticyclic citrullinated peptide antibodies in pediatric rheumatology. Curr Rheumatol Rep 2008, 10:156-163. 10.1007/s11926-008-0027-4, 18460272.
9. Fall N, Barnes M, Thornton S, Luyrink L, Olson J, Ilowite NT, Gottlieb BS, Griffin T, Sherry DD, Thompson S, Glass DN, Colbert RA, Grom AA. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum 2007, 56:3793-3804. 10.1002/art.22981, 17968951.
10. Macaubas C, Nguyen K, Deshpande C, Phillips C, Peck A, Lee T, Park J, Sandborg C, Mellins E. Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states. Clin Immunol 2010, 134:206-216. 10.1016/j.clim.2009.09.010, 2818241, 19879195.
11. Maeno N, Takei S, Nomura Y, Imanaka H, Hokonohara M, Miyata K. Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al. Arthritis Rheum 2002, 46:2539-2541. 10.1002/art.10389, 12355506.
12. Lotito APN, Campa A, Silva CAA, Kiss MHB, Mello SBV. Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. J Rheumatol 2007, 34:823-830.
13. Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003, 142:292-296. 10.1067/mpd.2003.110, 12640378.
14. Lequerre T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O, Kone-Paut I, Michel M, Dernis E, Khellaf M, Limal N, Job-Deslandre C, Fautrel B, Le Loet X, Sibilia J. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 2008, 67:302-308.
15. Iwamoto M, Nara H, Hirata D, Minota S, Nishimoto N, Yoshizaki K. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease. Arthritis Rheumat 2002, 46:3388-3389. 10.1002/art.10620, 12483747.
16. Masters S, Simon A, Aksentijevich I, Kastner D. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Ann Rev Immunol 2009, 27:621-668.
17. Mellins E, Macaubas C, Grom A. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol 2011, 7:416-426. 10.1038/nrrheum.2011.68, 21647204.
18. Gattorno M, Piccini A, Lasiglie D, Tassi S, Brisca G, Carta S, Delfino L, Ferlito F, Pelagatti MA, Caroli F, Buoncompagni A, Viola S, Loy A, Sironi M, Vecchi A, Ravelli A, Martini A, Rubartelli A. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2008, 58:1505-1515. 10.1002/art.23437, 18438814.
19. Nigrovic PA, Mannion M, Prince FH, Zeft A, Rabinovich CE, van Rossum MA, Cortis E, Pardeo M, Miettunen PM, Janow G, Birmingham J, Eggebeen A, Janssen E, Shulman AI, Son MB, Hong S, Jones K, Ilowite NT, Cron RQ, Higgins GC. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum 2011, 63:545-555. 10.1002/art.30128, 21280009.
20. Quartier P, Allantaz F, Cimaz R, Pillet P, Messiaen C, Bardin C, Bossuyt X, Boutten A, Bienvenu J, Duquesne A, Richer O, Chaussabel D, Mogenet A, Banchereau J, Treluyer J-M, Landais P, Pascual V. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis 2011, 70:747-754. 10.1136/ard.2010.134254, 3070271, 21173013.
21. Griffin T, Barnes M, Ilowite N, Olson J, Sherry D, Gottlieb B, Aronow B, Pavlidis P, Hinze C, Thornton S, Thompson S, Grom A, Colbert R, Glass D. Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets. Arthritis Rheum 2009, 60:2113-2123. 10.1002/art.24534, 2741130, 19565504.
22. van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Voskuyl AE, Rustenburg F, Baggen JM, Ibrahim SM, Fero M, Dijkmans BA, Tak PP, Verweij CL. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 2007, 66:1008-1014. 10.1136/ard.2006.063412, 1954704, 17223656.
23. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003, 197:711-723. 10.1084/jem.20021553, 2193846, 12642603.
24. Popper S, Shimizu C, Shike H, Kanegaye J, Newburger J, Sundel R, Brown P, Burns J, Relman D. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol 2007, 8:R261. 10.1186/gb-2007-8-12-r261, 2246263, 18067656.
25. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005, 201:1479-1486. 10.1084/jem.20050473, 2213182, 15851489.
26. Ogilvie EM, Khan A, Hubank M, Kellam P, Woo P. Specific gene expression profiles in systemic juvenile idiopathic arthritis. Arthritis Rheum 2007, 56:1954-1965. 10.1002/art.22644, 17530721.
27. Allantaz F, Chaussabel D, Stichweh D, Bennett L, Allman W, Mejias A, Ardura M, Chung W, Wise C, Palucka K, Ramilo O, Punaro M, Banchereau J, Pascual V. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J Exp Med 2007, 204:2131-2144. 10.1084/jem.20070070, 2118700, 17724127.
28. Ishikawa S, Mima T, Aoki C, Yoshio-Hoshino N, Adachi Y, Imagawa T, Mori M, Tomiita M, Iwata N, Murata T, Miyoshi M, Takei S, Aihara Y, Yokota S, Matsubara K, Nishimoto N. Abnormal expression of the genes involved in cytokine networks and mitochondrial function in systemic juvenile idiopathic arthritis identified by DNA microarray analysis. Ann Rheum Dis 2009, 68:264-272. 10.1136/ard.2007.079533, 18388159.
29. Barnes M, Grom A, Thompson S, Griffin T, Pavlidis P, Itert L, Fall N, Sowders D, Hinze C, Aronow B, Luyrink L, Srivastava S, Ilowite N, Gottlieb B, Olson J, Sherry D, Glass D, Colbert R. Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. Arthritis Rheum 2009, 60:2102-2112. 10.1002/art.24601, 2782469, 19565513.
30. Palmisani E, Solari N, Magni-Manzoni S, Pistorio A, Lab E, Panigada S, Martini A, Ravelli A. Correlation between juvenile idiopathic arthritis activity and damage measures in early, advanced, and longstanding disease. Arthritis Rheum 2006, 55:843-849. 10.1002/art.22357, 17139659.
31. Ling XB, Lau K, Deshpande C, Park JL, Milojevic D, Macaubas C, Xiao C, Lopez-Avila V, Kanegaye J, Burns JC, Cohen H, Schilling J, Mellins ED. Urine peptidomic and targeted plasma protein analyses in the diagnosis and monitoring of systemic juvenile idiopathic arthritis. Clin Proteomics 2010, 6:175-193. 10.1007/s12014-010-9058-8, 2970804, 21124648.
32. Ling X, Park J, Carroll T, Nguyen K, Lau K, Macaubas C, Chen E, Lee T, Sandborg C, Milojevic D, Kanegaye J, Gao S, Burns J, Schilling J, Mellins E. Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications. Proteomics 2010, 10:4415-4430. 10.1002/pmic.201000298, 21136595.
33. Sandborg CI, Nepom BS, Mellins E. Juvenile arthritis. Clinical Immunology 2001, 62.1-62.13. London: Mosby, Rich RR, Fleisher T, Shearer W, Kotzin B, Schroeder H, 2.
34. Sandborg C, Holmes TH, Lee T, Biederman K, Bloch DA, Emery H, McCurdy D, Mellins ED. Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis. J Rheumatol 2006, 33:2322-2329.
35. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007, 369:767-778. 10.1016/S0140-6736(07)60363-8, 17336654.
36. Srivastava S, Macaubas C, Deshpande C, Alexander H, Chang S-Y, Sun Y, Park J, Lee T, Begovich A, Mellins E. Monocytes are resistant to apoptosis in systemic juvenile idiopathic arthritis. Clin Immunol 2010, 136:257-268. 10.1016/j.clim.2010.04.003, 2902595, 20462799.
37. Alizadeh A, Eisen M, Davis R, Ma C, Sabet H, Tran T, Powell J, Yang L, Marti G, Moore D, Hudson JJ, Chan W, Greiner T, Weisenburger D, Armitage J, Lossos I, Levy R, Botstein D, Brown P, Staudt L. The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol 1999, 64:71-78. 10.1101/sqb.1999.64.71, 11232339.
38. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511. 10.1038/35000501, 10676951.
39. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98:5116-5121. 10.1073/pnas.091062498, 33173, 11309499.
40. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95:14863-14868. 10.1073/pnas.95.25.14863, 24541, 9843981.
41. Macaubas C, Nguyen K, Peck A, Buckingham J, Deshpande C, Wong E, Alexander H, Chang S-Y, Begovich A, Sun Y, Park J, Pan K-H, Lin R, Lih C-J, Augustine E, Phillips C, Hadjinicolaou A, Lee T, Mellins E. Alternative activation in systemic juvenile idiopathic arthritis monocytes. Clin Immunol 2012, 142:362-372. 10.1016/j.clim.2011.12.008, 22281427.
42. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S, Guo N, Muruganujan A, Doremieux O, Campbell MJ, Kitano H, Thomas PD. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005, 33:D284-D288. 10.1093/nar/gki418, 540032, 15608197.
43. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Moser K, Ortmann WA, Espe KJ, Balasubramanian S, Hughes KM, Chan JP, Begovich A, Chang SY, Gregersen PK, Behrens TW. Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes Immun 2004, 5:347-353. 10.1038/sj.gene.6364098, 15175644.
44. Wu MC, Zhang L, Wang Z, Christiani DC, Lin X. Sparse linear discriminant analysis for simultaneous testing for the significance of a gene set/pathway and gene selection. Bioinformatics 2009, 25:1145-1151. 10.1093/bioinformatics/btp019, 2732305, 19168911.
45. Ling X, Cohen H, Jin J, Lau I, Schilling J. FDR made easy in differential feature discovery and correlation analyses. Bioinformatics 2009, 25:1461-1462. 10.1093/bioinformatics/btp176, 19376824.
46. Gottlieb T, Leal JFM, Seger R, Taya Y, Oren M. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene 2002, 21:1299-1303. 10.1038/sj.onc.1205181, 11850850.
47. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E. Natural-killer cells and dendritic cells: "l'union fait la force". Blood 2005, 106:2252-2258. 10.1182/blood-2005-03-1154, 15933055.
48. Anandarajah A. Role of RANKL in bone diseases. Trends Endocrinol Metab 2009, 20:88-94. 10.1016/j.tem.2008.10.007, 19185505.
49. Shao L, Fujii H, Colmegna I, Oishi H, Goronzy JJ, Weyand CM. Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J Exp Med 2009, 206:1435-1449. 10.1084/jem.20082251, 2715066, 19451263.
50. Rasheed N, Wang X, Niu Q-T, Yeh J, Li B. Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis. Hum Mol Genet 2006, 15:1938-1948. 10.1093/hmg/ddl116, 16644862.
51. Ranger AM, Gerstenfeld LC, Wang J, Kon T, Bae H, Gravallese EM, Glimcher MJ, Glimcher LH. The nuclear factor of activated T cells (Nfat) transcription factor Nfatp (Nfatc2) Is a repressor of chondrogenesis. J Exp Med 2000, 191:9-22. 10.1084/jem.191.1.9, 2195796, 10620601.
52. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003, 17:2205-2232. 10.1101/gad.1102703, 12975316.
53. Ghosh S, Koralov SB, Stevanovic I, Sundrud MS, Sasaki Y, Rajewsky K, Rao A, Müller MR. Hyperactivation of nuclear factor of activated T cells 1 (NFAT1) in T cells attenuates severity of murine autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2010, 107:15169-15174. 10.1073/pnas.1009193107, 2930568, 20696888.
54. Gierut A, Perlman H, Pope RM. Innate immunity and rheumatoid arthritis. Rheum Dis Clin North Am 2010, 36:271-296. 10.1016/j.rdc.2010.03.004, 2937347, 20510234.
55. Khan F, Galarraga B, Belch JJF. The role of endothelial function and its assessment in rheumatoid arthritis. Nat Rev Rheumatol 2010, 6:253-261. 10.1038/nrrheum.2010.44, 20351705.
56. Stephan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM. Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 1993, 11:451-456.
57. Crowson CS, Rahman MU, Matteson EL. Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis. J Rheumatol 2009, 36:1606-1610. 10.3899/jrheum.081188, 19531760.
58. Kostik MM, Klyushina AA, Moskalenko MV, Scheplyagina LA, Larionova VI. Glucocorticoid receptor gene polymorphism and juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2011, 9:2. 10.1186/1546-0096-9-2, 3035022, 21232135.
59. Russo RA, Katsicas MM. Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents. J Rheumatol 2009, 36:1078-1082. 10.3899/jrheum.090952, 19435972.
60. Otten MH, Prince FH, Armbrust W, ten Cate R, Hoppenreijs EP, Twilt M, Koopman-Keemink Y, Gorter SL, Dolman KM, Swart JF, van den Berg JM, Wulffraat NM, van Rossum MA, van Suijlekom-Smit LW. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis. JAMA 2011, 306:2340-2347. 10.1001/jama.2011.1671, 22056397.
61. Kim K-W, Cho M-L, Park M-K, Yoon C-H, Park S-H, Lee S-H, Kim H-Y. Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis. Arthritis Res Ther 2005, 7:R139-R148. 10.1186/ar1470, 1064895, 15642134.
62. Omoyinmi E, Hamaoui R, Pesenacker A, Nistala K, Moncrieffe H, Ursu S, Wedderburn LR, Woo P. Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis. Rheumatology (Oxford) 2012,
63. Thompson S, Barnes M, Griffin T, Grom A, Glass D. Heterogeneity in juvenile idiopathic arthritis: impact of molecular profiling based on DNA polymorphism and gene expression patterns. Arthritis Rheum 2010, 62:2611-2615. 10.1002/art.27561, 20496366.
64. Macaubas C, Nguyen K, Milojevic D, Park J, Mellins E. Oligoarticular and polyarticular JIA: epidemiology and pathogenesis. Nat Rev Rheumatol 2009, 5:616-626. 10.1038/nrrheum.2009.209, 19806151.
65. Lin Y-T, Wang C-T, Gershwin ME, Chiang B-L. The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev 2011, 10:482-489. 10.1016/j.autrev.2011.02.001, 21320644.
66. Wulffraat NM, Rijkers GT, Elst E, Brooimans R, Kuis W. Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology 2003, 42:375-379. 10.1093/rheumatology/keg074, 12595640.
67. de Kleer I, Vastert B, Klein M, Teklenburg G, Arkesteijn G, Yung GP, Albani S, Kuis W, Wulffraat N, Prakken B. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 2006, 107:1696-1702. 10.1182/blood-2005-07-2800, 16263787.
68. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier K, Sedger L, Willis CR, Brasel K, Morrissey PJ, Stocking K, Schuh JCL, Joyce S, Peschon JJ. Reversible defects in natural killer and memory Cd8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000, 191:771-780. 10.1084/jem.191.5.771, 2195858, 10704459.
69. Fife MS, Gutierrez A, Ogilvie EM, Stock CJW, Samuel JM, Thomson W, Mack LF, Lewis CM, Woo P. Novel IL10 gene family associations with systemic juvenile idiopathic arthritis. Arthritis Res Ther 2006, 8:R148. 10.1186/ar2041, 1779449, 16959027.
70. Moller J, Paul D, Ganser G, Range U, Gahr M, Kelsch R, Rosen-Wolff A, Hedrich C. IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA). Clin Exp Rheumatol 2010, 28:912-918.
71. Prots I, Skapenko A, Wendler J, Mattyasovszky S, Yon C, Spriewald B, Burkhardt H, Rau R, Kalden J, Lipsky P, Schulze Koops H. Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis. Arthritis Rheum 2006, 54:1491-1500. 10.1002/art.21832, 16646030.
72. Spelling P, Bonfa E, Caparbo VF, Pereira RM. Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker?. Scand J Rheumatol 2008, 37:439-444. 10.1080/03009740802116224, 18802807.
73. Dechanet J, Briolay J, Rissoan M, Chomarat P, Galizzi J, Banchereau J, Miossec P. IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J Immunol 1993, 151:4908-4917.
74. Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegrd D, van den Berg WB. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res 1999, 1:81-91. 10.1186/ar14, 17779, 11056663.
75. Myers LK, Tang B, Stuart JM, Kang AH. The role of IL-4 in regulation of murine collagen-induced arthritis. Clin Immunol 2002, 102:185-191. 10.1006/clim.2001.5162, 11846461.
76. Horsfall A, Butler D, Marinova L, Warden P, Williams R, Maini R, Feldmann M. Suppression of collagen-induced arthritis by continuous administration of IL-4. J Immunol 1997, 159:5687-5696.
77. Cao Y, Brombacher F, Tunyogi Csapo M, Glant T, Finnegan A. Interleukin-4 regulates proteoglycan-induced arthritis by specifically suppressing the innate immune response. Arthritis Rheum 2007, 56:861-870. 10.1002/art.22422, 17330244.
78. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 1989, 142:3857-3861.
79. Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 1989, 86:3803-3807. 10.1073/pnas.86.10.3803, 287229, 2786204.
80. Lubberts E, Joosten LA, Chabaud M, van Den Bersselaar L, Oppers B, Coenen-De Roo CJ, Richards CD, Miossec P, van Den Berg WB. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest 2000, 105:1697-1710. 10.1172/JCI7739, 378501, 10862785.
81. Koenders M, Lubberts E, Oppers Walgreen B, van den Bersselaar L, Helsen M, Kolls J, Joosten LAB, van den Berg WB. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1. Arthritis Rheum 2005, 52:975-983. 10.1002/art.20885, 15751058.
82. Cooney LA, Towery K, Endres J, Fox DA. Sensitivity and Resistance to Regulation by IL-4 during Th17 Maturation. J Immunol 2011, 187:4440-4450. 10.4049/jimmunol.1002860, 21949021.
83. Vojinovic J, Damjanov N, D'Urzo C, Furlan A, Susic G, Pasic S, Iagaru N, Stefan M, Dinarello C. Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2011, 63:1452-1458. 10.1002/art.30238, 21538322.
84. Barnes M, Grom A, Thompson S, Griffin T, Luyrink L, Colbert R, Glass D. Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis. Arthritis Rheum 2010, 62:3249-3258. 10.1002/art.27657, 3018072, 20662067.
85. Jarvis J, Jiang K, Frank M, Knowlton N, Aggarwal A, Wallace C, McKee R, Chaser B, Tung C, Smith L, McGhee J, Chen Y, Osban J, O'Neil K, Centola M. Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis. Arthritis Rheum 2009, 60:1488-1495. 10.1002/art.24450, 3063001, 19404961.
86. Barnes MG, Aronow BJ, Luyrink LK, Moroldo MB, Pavlidis P, Passo MH, Grom AA, Hirsch R, Giannini EH, Colbert RA, Glass DN, Thompson SD. Gene expression in juvenile arthritis and spondyloarthropathy: pro-angiogenic ELR+ chemokine genes relate to course of arthritis. Rheumatology 2004, 43:973-979. 10.1093/rheumatology/keh224, 15150433.